Cost control steps, operational efficiency drive Sygene's Q3 net up by 11%

Consolidated revenue rises by 11.59 per cent to Rs 601.6 crore

Biocon's custom research organisation (CRO) Syngene International Limited reported an 11 per cent rise in its consolidated net profit for the quarter ended December 31, 2020 (Q3) on account of cost control measures and operational efficiency.

Apart from continued focus on cost control measures, a sustained performance from all divisions saw the company post a consolidated net profit of Rs 102.2 crore in Q3 of FY21, up from Rs 91.8 crore. 

Syngene's consolidated revenue in the quarter went up by 11.59 per cent to Rs 601.6 crore as against Rs 539.1 crore in the corresponding period last year. The third